Mesenchymal Stem Cell Transplantation
"Mesenchymal Stem Cell Transplantation" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Transfer of MESENCHYMAL STEM CELLS between individuals within the same species (TRANSPLANTATION, HOMOLOGOUS) or transfer within the same individual (TRANSPLANTATION, AUTOLOGOUS).
Descriptor ID |
D045164
|
MeSH Number(s) |
E02.095.147.500.500.625 E04.936.225.687.625
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mesenchymal Stem Cell Transplantation".
Below are MeSH descriptors whose meaning is more specific than "Mesenchymal Stem Cell Transplantation".
This graph shows the total number of publications written about "Mesenchymal Stem Cell Transplantation" by people in this website by year, and whether "Mesenchymal Stem Cell Transplantation" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 2 | 2 |
2007 | 1 | 0 | 1 |
2008 | 0 | 3 | 3 |
2009 | 1 | 1 | 2 |
2010 | 3 | 2 | 5 |
2011 | 2 | 0 | 2 |
2012 | 4 | 0 | 4 |
2013 | 4 | 1 | 5 |
2014 | 5 | 0 | 5 |
2015 | 1 | 1 | 2 |
2016 | 4 | 1 | 5 |
2017 | 4 | 1 | 5 |
2018 | 0 | 1 | 1 |
2019 | 0 | 1 | 1 |
2020 | 2 | 1 | 3 |
2021 | 3 | 0 | 3 |
2022 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mesenchymal Stem Cell Transplantation" by people in Profiles.
-
Comparison of the therapeutic effects between stem cells and exosomes in primary ovarian insufficiency: as promising as cells but different persistency and dosage. Stem Cell Res Ther. 2023 06 20; 14(1):165.
-
MSC Pretreatment for Improved Transplantation Viability Results in Improved Ventricular Function in Infarcted Hearts. Int J Mol Sci. 2022 Jan 08; 23(2).
-
Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10. Stem Cell Res Ther. 2021 07 07; 12(1):388.
-
Human Mesenchymal Stem Cell Therapy and Other Novel Treatment Approaches for Premature Ovarian Insufficiency. Reprod Sci. 2021 06; 28(6):1688-1696.
-
Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model. Cell Transplant. 2021 Jan-Dec; 30:963689720988502.
-
Modern Management of Perianal Crohn's Disease: A Review. Am Surg. 2021 Sep; 87(9):1361-1367.
-
Mesenchymal Stem Cells as a Bio Organ for Treatment of Female Infertility. Cells. 2020 10 08; 9(10).
-
Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature. J Med Case Rep. 2020 Jul 18; 14(1):108.
-
Lentiviral Gene Therapy for Bone Repair Using Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells. Hum Gene Ther. 2019 07; 30(7):906-917.
-
Gene Therapy for Bone Repair Using Human Cells: Superior Osteogenic Potential of Bone Morphogenetic Protein 2-Transduced Mesenchymal Stem Cells Derived from Adipose Tissue Compared to Bone Marrow. Hum Gene Ther. 2018 04; 29(4):507-519.